Related references
Note: Only part of the references are listed.HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019
Laia Bruni et al.
PREVENTIVE MEDICINE (2021)
ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer
Tatiana Galicia-Carmona et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis
Yimin Xu et al.
FRONTIERS IN IMMUNOLOGY (2021)
First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+cancers.
Alan Loh Ho et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.
Julius Strauss et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Initial results of a first-in-human, dose escalation study of a cell-based vaccine in HLA A*02+patients (pts) with recurrent, locally advanced or metastatic HPV16+solid tumors: SQZ-PBMC-HPV-101.
Antonio Jimeno et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer
Christiane S. Eberhardt et al.
NATURE (2021)
Causes and Consequences of HPV Integration in Head and Neck Squamous Cell Carcinomas: State of the Art
Harini Balaji et al.
CANCERS (2021)
Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL
Prakash K. Bhuyan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3
Youn Jin Choi et al.
CLINICAL CANCER RESEARCH (2020)
Human papillomavirus vaccine against cervical cancer: Opportunity and challenge
Renjie Wang et al.
CANCER LETTERS (2020)
Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-titer HBV Carrier Mice
Thomas Michler et al.
GASTROENTEROLOGY (2020)
Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer
Pippa F. Cosper et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
Bhishamjit S. Chera et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
Catherine de Martel et al.
LANCET GLOBAL HEALTH (2020)
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
Cornelis J. M. Melief et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The current epidemic of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2,169 patients
Martin Zamani et al.
EUROPEAN JOURNAL OF CANCER (2020)
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
Elizabeth T. H. Fontham et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
PD-L1 Expression and a High Tumor Infiltrate of CD8+Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma
Nora Wuerdemann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Profiling HPV-16-specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients
Kunal H. Bhatt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
A multi-centre, open-label phase II trial of the combination of VB10.16 and atezolizumab in patients with advanced or recurrent, non-resectable HPV16 positive cervical cancer
P. Hillemanns et al.
ANNALS OF ONCOLOGY (2020)
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial
Jin Won Youn et al.
LANCET ONCOLOGY (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
Pap smear accuracy for the diagnosis of cervical precancerous lesions
Elie Nkwabong et al.
TROPICAL DOCTOR (2019)
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Hyun Cheol Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
MHC-II invariant chain adjuvanted chimpanzee adenoviral and MVA hepatitis C vaccines elicit unprecedented levels of anti-viral T-cell immune responses in humans
Ilaria Esposito et al.
JOURNAL OF HEPATOLOGY (2019)
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up
Diane M. Harper et al.
GYNECOLOGIC ONCOLOGY (2019)
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
Vivek Verma et al.
NATURE IMMUNOLOGY (2019)
Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer
Gypsyamber D'Souza et al.
CANCER PREVENTION RESEARCH (2019)
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer A Phase 2 Clinical Trial
Erminia Massarelli et al.
JAMA ONCOLOGY (2019)
A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins
Gemma Hancock et al.
SCIENTIFIC REPORTS (2019)
Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology
Andriniaina Andy Nkili-Meyong et al.
SCIENTIFIC REPORTS (2019)
Therapeutic HPV vaccines
Gemma Hancock et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2018)
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Ranee Mehra et al.
BRITISH JOURNAL OF CANCER (2018)
Screening for Human Papillomavirus-Driven Oropharyngeal Cancer: Considerations for Feasibility and Strategies for Research
Aimee R. Kreimer et al.
CANCER (2018)
A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer
Partha Basu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Dysfunction of HPV16-specific CD8+T cells derived from oropharyngeal tumors is related to the expression of Tim-3 but not PD-1
Kamila Hladikova et al.
ORAL ONCOLOGY (2018)
Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma
Nicole V. Anayannis et al.
PLOS ONE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8+ T Cells in Head and Neck Cancer
Krishna et al.
CANCER RESEARCH (2018)
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV thorn Oral Cancers
Stephanie Dorta-Estremera et al.
CANCER RESEARCH (2018)
Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma
Miaomiao Ma et al.
INFECTIOUS AGENTS AND CANCER (2018)
Elevated HPV16 E1 Expression Is Associated with Cervical Cancer Progression
Fern Baedyananda et al.
INTERVIROLOGY (2017)
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Breadth of T Cell Responses After Immunization with Adenovirus Vectors Encoding Ancestral Antigens or Polyvalent Papillomavirus Antigens
E. Ragonnaud et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
Sanja Stevanovic et al.
SCIENCE (2017)
Integration of Human Papillomavirus Genomes in Head and Neck Cancer: Is It Time to Consider a Paradigm Shift?
Iain M. Morgan et al.
VIRUSES-BASEL (2017)
Serum Immune Profiling for Early Detection of Cervical Disease
Radwa Ewaisha et al.
THERANOSTICS (2017)
Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix
Emeline Ragonnaud et al.
JOURNAL OF IMMUNOTHERAPY (2017)
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
Mariette I. E. van Poelgeest et al.
CLINICAL CANCER RESEARCH (2016)
GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial
Pierre Van Damme et al.
CLINICAL CANCER RESEARCH (2016)
CD8+ T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer
Liam Masterson et al.
EUROPEAN JOURNAL OF CANCER (2016)
High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Shariq S. Khwaja et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Elective Nodal Irradiation and Patterns of Failure in Head and Neck Cancer After Primary Radiation Therapy
Julie Kjems et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Programmable protein arrays for immunoprofiling HPV-associated cancers
Radwa Ewaisha et al.
PROTEOMICS (2016)
Moving forward with human papillomavirus immunotherapies
Nicolas Cuburu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
Leo Swadling et al.
VACCINES (2016)
HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx
Kristina R. Dahlstrom et al.
CLINICAL CANCER RESEARCH (2015)
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
Cornelia L. Trimble et al.
LANCET (2015)
Next generation prophylactic human papillomavirus vaccines
John T. Schiller et al.
LANCET ONCOLOGY (2015)
Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters
Torbjorn Ramqvist et al.
ORAL ONCOLOGY (2015)
HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status
Karen S. Anderson et al.
ORAL ONCOLOGY (2015)
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
Domenica Lorusso et al.
GYNECOLOGIC ONCOLOGY (2014)
Regression of Human Papillomavirus Intraepithelial Lesions Is Induced by MVA E2 Therapeutic Vaccine
Ricardo Rosales et al.
HUMAN GENE THERAPY (2014)
Variable transcript expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer
Sung Ho Um et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions
Leonel Maldonado et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Human Papillomavirus Prevalence in Oropharyngeal Cancer before Vaccine Introduction, United States
Martin Steinau et al.
EMERGING INFECTIOUS DISEASES (2014)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
In vivo HPV 16 E5 mRNA: Expression pattern in patients with squamous intra-epithelial lesions of the cervix
Laura Lorenzon et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
The HPV transcriptome in HPV16 positive cell lines
Markus Schmitt et al.
MOLECULAR AND CELLULAR PROBES (2011)
HPV16 E2 Is an Immediate Early Marker of Viral Infection, Preceding E7 Expression in Precursor Structures of Cervical Carcinoma
Yuezhen Xue et al.
CANCER RESEARCH (2010)
A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6-and E7-specific T-cell responses
Yin Ling Woo et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
HPV-16 E5 down-regulates expression of surface HLA class I by CD8 T cells
M. S. Campo et al.
VIROLOGY (2010)
Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus-Related Head and Neck Cancer
William C. Spanos et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions
Svetlana Vinokurova et al.
CANCER RESEARCH (2008)
MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines
Peter Johannes Holst et al.
JOURNAL OF IMMUNOLOGY (2008)
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins
Mako Narisawa-Saito et al.
CANCER SCIENCE (2007)
Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?
M. Pett et al.
JOURNAL OF PATHOLOGY (2007)
The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen:: Uncovering new tricks for an old virus
Maya F. Kotturi et al.
JOURNAL OF VIROLOGY (2007)
Resolution of cervical dysplasia is associated with T-cell proliferative responses to human papillomavirus type 16 E2
Stephanie Dillon et al.
JOURNAL OF GENERAL VIROLOGY (2007)
High number of intraepithelial CD8(+) tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer
Sytse J. Piersma et al.
CANCER RESEARCH (2007)
Effectiveness of cervical cancer screening over cervical cancer mortality among Japanese women
Khandoker Aklimunnessa et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine
E. Garcia-Hernandez et al.
CANCER GENE THERAPY (2006)
Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer
Hugo Arias-Pulido et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Cervical cancer incidence in Denmark over six decades (1943-2002)
M Kyndi et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2006)
Human papillomavirus (HPV) type 16-specific CD8+T cell responses in women with high grade vulvar intraepithelial neoplasia
RW Todd et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Bovine papillomavirus replicative helicase E1 is a target of the ubiquitin ligase APC
F Mechali et al.
JOURNAL OF VIROLOGY (2004)
Regulation of bovine papillomavirus replicative helicase E1 by the ubiquitin-proteasome pathway
MH Malcles et al.
JOURNAL OF VIROLOGY (2002)
Ubiquitin-fused and/or multiple papillomavirus early genes from cottontail rabbit as DNA vaccines
SA Leachman et al.
JOURNAL OF VIROLOGY (2002)
Papillomaviruses and cancer: From basic studies to clinical application
H zur Hausen
NATURE REVIEWS CANCER (2002)
Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens
M Nakagawa et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
